Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 184 | 184 | 184 |
Full Text Views | 15 | 15 | 15 |
PDF Downloads | 16 | 16 | 16 |
Chagas meningoencephalitis can present in immunocompromised patients after organ transplantation. We present the first reported instance in which metagenomic next-generation sequencing (mNGS) of cerebrospinal fluid diagnosed Chagas meningoencephalitis in a patient. The diagnosis of Chagas in this case underscores the role of mNGS in identifying rare or unexpected pathogens.
Disclosures: C. Y. Chiu is a co-founder of Delve Bio and serves on the scientific advisory boards for Delve Bio, Flightpath Biosciences, Biomeme, Mammoth Biosciences, BiomeSense, and Poppy Health. C. Y. Chiu receives research support from Delve Bio and Abbott Laboratories, Inc. V. Hemmige received funding from Merck for a pneumococcal vaccine study. Informed consent was obtained from the patient.
Current contact information: Jill Teitelbaum, Christina Coyle, and Phyu M. Thwe, Albert Einstein College of Medicine, Bronx, NY, E-mails: jill.teitelbaum@einsteinmed.edu, christina.coyle@einsteinmed.edu, and pthwe@montefiore.org. Shivank Madan, Snehal Patel, Mayuko Uehara, Rita Jermyn, and Vagish Hemmige, Montefiore Medical Center, Bronx, NY, E-mails: smadan@montefiore.org, snepatel@montefiore.org, muehara@montefiore.org, rjermyn@montefiore.org, and vahemmig@montefiore.org. Charles Y. Chiu, Department of Laboratory Medicine and UCSF Clinical Microbiology Laboratory, University of California San Francisco, San Francisco, CA, E-mail: charles.chiu@ucsf.edu.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 184 | 184 | 184 |
Full Text Views | 15 | 15 | 15 |
PDF Downloads | 16 | 16 | 16 |